179 related articles for article (PubMed ID: 18260714)
21. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
[TBL] [Abstract][Full Text] [Related]
22. Isolated full-thickness cervical stromal invasion warrants post-hysterectomy pelvic radiotherapy in FIGO stages IB-IIA uterine cervical carcinoma.
Moon SH; Wu HG; Ha SW; Lee HP; Kang SB; Song YS; Park NH; Kim JW; Park IA; Kim BH
Gynecol Oncol; 2007 Jan; 104(1):152-7. PubMed ID: 16935323
[TBL] [Abstract][Full Text] [Related]
23. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
[TBL] [Abstract][Full Text] [Related]
24. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
[TBL] [Abstract][Full Text] [Related]
25. Comparison of clinical outcomes of adenocarcinoma and adenosquamous carcinoma in uterine cervical cancer patients receiving surgical resection followed by radiotherapy: a multicenter retrospective study (KROG 13-10).
Noh JM; Park W; Kim YS; Kim JY; Kim HJ; Kim J; Kim JH; Yoon MS; Choi JH; Yoon WS; Kim JY; Huh SJ
Gynecol Oncol; 2014 Mar; 132(3):618-23. PubMed ID: 24486605
[TBL] [Abstract][Full Text] [Related]
26. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
[TBL] [Abstract][Full Text] [Related]
27. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
Covens A; Rosen B; Murphy J; Laframboise S; DePetrillo AD; Lickrish G; Colgan T; Chapman W; Shaw P
Gynecol Oncol; 2001 May; 81(2):133-7. PubMed ID: 11330939
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in node-positive patients with stage IB-IIB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy.
Kodama J; Seki N; Ojima Y; Nakamura K; Hongo A; Hiramatsu Y
Int J Gynaecol Obstet; 2006 May; 93(2):130-5. PubMed ID: 16563395
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
[TBL] [Abstract][Full Text] [Related]
30. Association between prognostic factors and disease-free survival of cervical cancer stage IB1 patients undergoing radical hysterectomy.
Chittithaworn S; Hanprasertpong J; Tungsinmunkong K; Geater A
Asian Pac J Cancer Prev; 2007; 8(4):530-4. PubMed ID: 18260723
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant small field pelvic radiation for patients with high risk, stage IB lymph node negative cervix carcinoma after radical hysterectomy and pelvic lymph node dissection. A pilot study.
Kridelka FJ; Berg DO; Neuman M; Edwards LS; Robertson G; Grant PT; Hacker NF
Cancer; 1999 Nov; 86(10):2059-65. PubMed ID: 10570432
[TBL] [Abstract][Full Text] [Related]
32. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of the recurrence of early stage bulky cervical carcinoma].
Hu JL; Wu LY; Li XG; Zhang R; Li N; Yao HW
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):378-81. PubMed ID: 22883461
[TBL] [Abstract][Full Text] [Related]
34. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
35. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases.
Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG
Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944
[TBL] [Abstract][Full Text] [Related]
36. What is the risk for parametrial involvement in women with early-stage cervical cancer with tumour <20 mm and with negative sentinel lymph nodes?
Klat J; Sevcik L; Simetka O; Graf P; Dvorackova J; Kraft O
Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):540-4. PubMed ID: 23216324
[TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis of 132 cases of cervical adenosquamous carcinoma and cervical adenocarcinoma].
Meng YH; Li S; Hu T; Ma D; Lu YP; Wang H
Chin J Cancer; 2010 Jan; 29(1):15-9. PubMed ID: 20038304
[TBL] [Abstract][Full Text] [Related]
38. Microscopic evaluation of lymph-node-bearing tissue in early-stage cervical cancer: a dual-institution review.
Milam MR; Abaid L; dos Reis R; Frumovitz M; Gehrig PA; Livasy C; Broaddus RR; Ramirez PT
Ann Surg Oncol; 2010 Apr; 17(4):1106-10. PubMed ID: 20039215
[TBL] [Abstract][Full Text] [Related]
39. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
40. A comparison of stages IB1 and IB2 cervical cancers treated with radical hysterectomy. Is size the real difference?
Rutledge TL; Kamelle SA; Tillmanns TD; Gould NS; Wright JD; Cohn DE; Herzog TJ; Rader JS; Gold MA; Johnson GA; Walker JL; Mannel RS; McMeekin DS
Gynecol Oncol; 2004 Oct; 95(1):70-6. PubMed ID: 15385112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
